DC Field | Value | Language |
dc.contributor.author | Tomac, Olga | |
dc.contributor.author | Berdeu, Ion | |
dc.date.accessioned | 2021-11-01T13:59:35Z | |
dc.date.available | 2021-11-01T13:59:35Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | TOMAC, Olga, BERDEU, Ion. Epidemiological and clinical features of viral hepatitis A. In: One Health & Risk Management. 2021, vol. 2(suppl.), no. 4, p. 47. ISSN 2587-3466. | en_US |
dc.identifier.issn | 2587-3466 | |
dc.identifier.issn | 2587-3458 | |
dc.identifier.uri | https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/issue/view/17/18 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/18268 | |
dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova | en_US |
dc.description.abstract | Introduction. Viral hepatitis A (VHA) is an acute, self-limited, caused by the hepatitis A
virus which belongs to the genus Hepatovirus. VHA continues to be a widespread infection
on all continents, with the highest prevalence in children - 75-80%. In France, the annual
morbidity through viral hepatitis A is 1.5‱, in Romania is 20.08‱and in Russian Federation is 5.46‱. More often, VHA is spread in poor countries and poor hygienic. The aim of
the study is to analyze the multiannual morbidity of VHA and clinical peculiarities of patients hospitalized with VHA infection.
Material and methods. This research is a descriptive observational epidemiological study,
in which morbidity data of VHA were analyzed. The following were used as information
sources: Form 2 of registration and evidence of diseases for the years 2004-2019 and patients diagnosed with VHA during 2016-2020 years, hospitalized in the infectious hospital
for children from mun. Chisinau. During this period where hospitalized 40 patients with
VHA. The following epidemiological indicators were analyzed: distribution of cases by age
groups, gender, living environment, seasonal distribution.
Results. Analyzing the multiannual dynamics morbidity of viral hepatitis A in the Republic
of Moldova during the 2004-2019 years, we found a decrease in morbidity from 84.0‱in
2004 to 2.05‱ in 2019, the multiannual average morbidity being 13.16‱. In mun. Chisinau, during the 2004-2019 years, morbidity had a pronounced decreasing trend from
48.08‱ in 2004 to 0.36‱ 2019, with an average of 6,28‱. Depending on the residence
place, we found an increased prevalence of the number of cases in rural areas with an average of 16.77‱, but in urban areas, the average morbidity was 7.62‱, being approximately 2.2 times lower than in rural areas. The average incidence of viral hepatitis A is
much higher among children – 51.42‱, compared to 4.66‱ among adults.
Following the study conducted on the basis of medical records, we found that the peak incidence of viral hepatitis during the 2016-2020 years, was recorded in October-December
months. Most parents have requested medical help on the 2nd - 5th day of the disease, and
average length of stay was 14 days. Most of the children who were diagnosed with viral
hepatitis A, attended an educational institution, 26 children (65.0%) attended school and
12 children (30.0%) attended kindergarten. During the 2016-2020 years, there was a predominance of the 7-17 years age group with 27 registered cases (67.5%), followed by the
3-6 years age group with 10 cases (25.0%), and only 3 cases of viral hepatitis A were registered in the 0-2 years age group. Out of 40 patients, 34 developed jaundice, 6 patients -
non-jaundice form of the disease. The jaundice form is about 5.6 times more common than
the non-jaundiced. The diagnosis of viral hepatitis A was established by ELISA method. The
treatment of VHA is mainly symptomatic and has an important detoxifying role, also being
used hepatoprotectors and enzymatic drugs.
Conclusions. Over the past year’s incidence of hepatitis A is decreasing, with an average
morbidity of 13.16‱. The most affected are children aged 7-17 years who attend the
school. The most common among hospitalized children is jaundiced form with an average
of 14 days of hospitalization. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Asociația de Biosiguranță și Biosecuritate din Republica Moldova | en_US |
dc.relation.ispartof | One Health & Risk Management: The National Scientific Conference with international participation ”ONE HEALTH” approach in a changing world | en_US |
dc.subject | viral hepatitis A | en_US |
dc.subject | hepatoprotectors | en_US |
dc.subject | morbidity | en_US |
dc.subject | jaundice | en_US |
dc.title | Epidemiological and clinical features of viral hepatitis A | en_US |
dc.type | Other | en_US |
Appears in Collections: | One Health & Risk Management Vol. 2 No 4, 2021 Supplement
|